Skip to main content
Premium Trial:

Request an Annual Quote

Zyomyx Raises Another $10M in Equity Financing

NEW YORK, Feb. 12 (GenomeWeb News) - Protein array company Zyomyx has raised $10 million in additional venture capital, the company said yesterday.

 

The financing round was led by CSFB Private Equity, which was joined by existing investors Alloy Ventures, Lilly BioVentures, Hambrecht & Quist Capital Management, Mediphase Venture Partners, and Bio One Capital.

 

Zyomyx plans to use the funding to expand its line of products. The company wants to launch a murine cytokine biochip in April, followed by other biochips later this year.

 

The Scan

Interfering With Invasive Mussels

The Chicago Tribune reports that researchers are studying whether RNA interference- or CRISPR-based approaches can combat invasive freshwater mussels.

Participation Analysis

A new study finds that women tend to participate less at scientific meetings but that some changes can lead to increased involvement, the Guardian reports.

Right Whales' Decline

A research study plans to use genetic analysis to gain insight into population decline among North American right whales, according to CBC.

Science Papers Tie Rare Mutations to Short Stature, Immunodeficiency; Present Single-Cell Transcriptomics Map

In Science this week: pair of mutations in one gene uncovered in brothers with short stature and immunodeficiency, and more.